Dr. James H. Peace II, MD

Dr. Peace practices at Diabetic Eye Medical Clinic in Inglewood, California.

Dr. Peace's NPI, 1497836423, was assigned on October 17, 2006. Dr. Peace graduated from University of North Carolina School of Medicine in 1982. Dr. Peace's California license number on file is C41199.

Dr. Peace's primary practice is Diabetic Eye Medical Clinic, at 431 N Prairie Ave, Inglewood, CA 90301-1413. The practice phone is (310) 671-7172.

Dr. Peace's primary practice is Diabetic Eye Medical Clinic in Inglewood, California. Dmand AI also links Dr. Peace to 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Peace practices, 2 sites in all. Vendor and product names are available with a free account.

Retina specialist is Dr. Peace's primary specialty in the NPI Registry, under taxonomy code 207WX0107X. Dr. Peace is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Peace's licenses on file in 3 states: California, North Carolina and Illinois.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, conjunctivitis, dry eye, eyelid inflammation, glaucoma and glaucoma surgery among the conditions Dr. Peace treats.

CMS data shows 5,749 Medicare services from Dr. Peace across 23 procedure codes in 2024, for 980 Medicare patients. Medicare paid $385,598 for them.

CMS counts 980 Medicare patients who saw Dr. Peace in 2024. The largest group is 65 to 74, with 502 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 82% are also on Medicaid. Their average risk score is 1.72, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Peace's median patient age at 64, with 60% women.

In 2024, Dr. Peace wrote 7,824 Medicare Part D claims for 1,246 patients. 46% of them were for generic drugs. CMS names the drug for 7,706 of them, across 34 drugs with 11 or more claims each, at $1,094,798 in total drug cost. In 2023, CMS named 7,909 claims across 36 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Peace for performance year 2024, reported individually. Dr. Peace accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 122 procedures of cataract surgery by Dr. Peace, more than 77% of the clinicians it reports for that procedure.

Dmand AI links 14 papers to Dr. Peace, published from 2011 to 2023. 2018 was the busiest year, with 2. The most frequent topics are Double-Blind Method, Intraocular Pressure and Ophthalmic Solutions. Dr. Peace has published most often in Clin Ophthalmol. Dr. Peace's most frequent co-authors are Sherif Mostafa El-Harazi, MD, MPH, Jennifer Lee Kim, MD and Mahmood F. Mafee, MD.

Dmand AI links Dr. Peace to 2 clinical trials. Conditions studied include Glaucoma and Ocular Hypertension. Bausch & Lomb Incorporated sponsors the most, 2. Open Payments lists research payments to Dr. Peace that name 2 trials.

CMS Open Payments shows 554 general payments to Dr. Peace from 37 drug and device companies from 2016 to 2025. Compensation for serving as faculty or as a speaker for a medical education program make up the largest share, 35% of the total. Bausch & Lomb Americas Inc. paid the most, $45,834. It also lists 5 research payments totaling $155,152 from 2016 to 2019, naming 2 clinical trials.

Dr. Peace graduated from University of North Carolina School of Medicine in 1982.

Dr. Peace is in network with 10 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.